XOMA - NASDAQ

XOMA Royalty Corp.

XOMA·NASDAQ

$41.92

+0.55%

HealthcareBiotechnology

XOMA Royalty Corp. operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$525.72M

EPS1.5300

P/E Ratio27.40

Earnings Date07/30/2026

272.70M

Assets

23%

3Y+94.0%

5Y+118.0%

10Y+851.0%

168.74M

Total Liabilities

21%

3Y+931.0%

5Y+334.0%

10Y+122.0%

103.96M

Total Equity

27%

3Y-16.0%

5Y+20.0%

10Y-320.0%

XOMA Royalty Corp. Funding & Solvency Profile

XOMA · NASDAQ

Current Assets

Cash & Cash Equivalents82.91M

Net Receivables4.90M

Inventory0.00

Other Current Assets29.45M

Total Current Assets117 M

Non-Current Assets

Property, Plant & Equipment277.00K

Goodwill & Intangible Assets44.76M

Long-Term Investments106.38M

Other Non-Current Assets4.03M

Total Non-Current Assets111 M

Total Assets

272.70M

Financial Health Analysis

Current Ratio

3.37x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

1.62x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

82 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

43% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

Financial Health Insight

Mixed signals: Strong short-term liquidity provides comfort, but high overall leverage requires careful monitoring of debt servicing capabilities and refinancing risk.

XOMA Royalty Corp. Balance Sheet

XOMA • NASDAQ

XOMA Royalty Corp. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	82.9M	101.7M	153.3M	57.8M	93.3M	84.2M	56.7M	45.8M	43.5M	25.7M	65.8M	78.4M	101.7M	45.3M	48.3M	37.3M	23.9M	9.5M	22.5M	28M
Short-Term Investments	382K	3.5M	161K	335K	774K	0.0	0.0	0.0	0.0	0.0	496K	0.0	20M	40M	0.0	0.0	0.0	1.3M	16.1M	18.4M
Cash & Short-Term Investments	82.9M	105.2M	153.5M	58.2M	94.1M	84.2M	56.7M	45.8M	43.5M	25.7M	66.3M	78.4M	121.6M	85.3M	48.3M	37.3M	23.9M	10.8M	38.6M	46.4M
Net Receivables	4.9M	17M	15.2M	2.4M	209K	1.8M	2.9M	1.5M	397K	566K	4.1M	3.3M	3.8M	8.2M	12.3M	20.9M	7.2M	16.7M	12.1M	13.4M
Accounts Receivables	4.9M	1.8M	1M	1K	209K	263K	2.9M	1.5M	397K	566K	3.7M	3M	3.7M	7.5M	11.8M	20.9M	7.2M	16.7M	11.7M	11.6M
Other Receivables	0.0	15.2M	14.2M	2.4M	0.0	1.5M	0.0	0.0	0.0	0.0	351K	316K	50K	772K	512K	0.0	0.0	0.0	480K	439K
Inventory	0.0	0.0	0.0	0.0	0.0	1.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8M	7.1M	5.4M
Prepaids	0.0	2.1M	0.0	0.0	613K	443K	352K	378K	327K	852K	1.9M	1.9M	1.6M	2.3M	2M	712K	1M	1.3M	1.1M	1.1M
Other Current Assets	29.5M	1.3M	643K	725K	2M	0.0	0.0	0.0	327K	852K	0.0	2.1M	1.6M	2.3M	2M	712K	1M	9.9M	6.3M	5M
Total Current Assets	117.3M	125.6M	169.3M	61.3M	97M	88.1M	60M	47.6M	44.2M	27.2M	72.2M	83.8M	127.1M	95.8M	62.7M	58.9M	32.2M	38.7M	58.1M	65.9M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	277K	351K	403K	36K	213K	380K	544K	59K	83K	1M	2M	5.1M	6.5M	8.1M	12.7M	14.9M	20.3M	26.8M	25.6M	22.4M
Intangible Assets	44.8M	25.9M	0.0	15.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	44.8M	25.9M	0.0	15.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	106.4M	64.3M	64.1M	63.7M	0.0	1.7M	681K	392K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	0.0	0.0	0.0	-63.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	4M	5.1M	533K	63.9M	69.4M	35.1M	34.5M	15.7M	657K	481K	664K	669K	1.3M	1.7M	2.6M	503K	402K	1.6M	1.1M	3.2M
Total Non-Current Assets	155.4M	95.7M	65M	79.1M	69.6M	37.2M	35.8M	16.2M	740K	1.5M	2.7M	5.8M	7.7M	9.8M	15.3M	15.4M	20.7M	28.5M	26.7M	25.6M
Total Assets	272.7M	221.3M	234.3M	140.4M	166.6M	125.3M	95.7M	63.8M	44.9M	28.7M	74.9M	89.6M	134.8M	105.7M	78M	74.3M	52.8M	67.2M	84.8M	91.5M
LIABILITIES
CURRENT LIABILITIES
Total Payables	3.6M	2.7M	653K	524K	2.5M	456K	614K	1.2M	3.3M	5.7M	6.8M	6M	9.6M	3.9M	2.1M	3.6M	2.9M	10M	7M	4.2M
Accounts Payable	2.2M	1.1M	653K	524K	1.1M	456K	614K	1.2M	1.7M	5.7M	6.8M	6M	9.6M	3.9M	2.1M	3.6M	2.9M	10M	7M	4.2M
Other Payables	1.4M	1.6M	0.0	0.0	1.5M	0.0	0.0	0.0	1.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	5.5M	1.4M	2M	470K	571K	888K	307K	702K	6.3M	3.9M	7.4M	7.4M	6.4M	3.1M	7.7M	8.6M	6M	8.6M	4.1M
Short Term Debt	15M	11.4M	5.5M	0.0	0.0	8.1M	5.2M	789K	0.0	17.9M	5.9M	19.2M	5.8M	3.4M	2.8M	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations (Current)	0.0	446K	54K	34K	195K	179K	163K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4M	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	280K	0.0	0.0	91K	0.0	0.0	0.0	1.6M	0.0	0.0	0.0	0.0	0.0	0.0	16K	0.0	0.0	0.0	0.0
Deferred Revenue	1.3M	1.4M	2.1M	1.9M	1.6M	1.5M	1.9M	1.3M	1.4M	899K	3.2M	1.1M	2.2M	3.4M	5.7M	17M	2.1M	9.1M	8M	9.6M
Other Current Liabilities	14.9M	3M	9.8M	2.4M	8.1M	1.6M	132K	2.1M	2M	1.8M	3.5M	2.8M	4.6M	6.7M	7.2M	24.2M	5M	1.9M	0.0	6.2M
Total Current Liabilities	34.8M	24.4M	19.5M	6.8M	13M	12.3M	8.9M	5.7M	7.4M	32.5M	23.3M	36.5M	29.6M	23.8M	21M	35.5M	18.7M	27M	23.6M	22.7M
NON-CURRENT LIABILITIES
Long Term Debt	116.6M	106.9M	118.5M	0.0	0.0	12.8M	27.1M	21.7M	14.6M	25.3M	42.8M	16.3M	35.2M	37.7M	33.5M	13.7M	13.3M	63.3M	0.0	46.8M
Deferred Revenue (Non-Current)	3.2M	4.4M	7.2M	9.6M	11.7M	13.5M	15.3M	17M	17.1M	18M	0.0	1.9M	4.1M	6.3M	7.5M	1.1M	2.9M	8.1M	10M	8.8M
Deferred Tax Liabilities (Non-Current)	103K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15M	0.0	0.0	0.0	-8.1M	-10M	-8.8M
Other Non-Current Liabilities	14.1M	3.2M	0.0	0.0	0.0	50K	43K	590K	32K	0.0	11.1M	31.8M	69.9M	16.4M	952K	353K	385K	-63.1M	0.0	0.0
Total Non-Current Liabilities	133.9M	115M	126.1M	9.6M	11.7M	26.6M	42.9M	39.3M	31.7M	43.4M	53.9M	50.1M	109.1M	60.4M	42M	15.1M	16.6M	71.6M	60.9M	107M
Capital Lease Obligations	0.0	929K	389K	34K	229K	408K	571K	0.0	0.0	69K	173K	16.3M	35.2M	37.7M	33.5M	0.0	13.3M	63.3M	50.9M	51.4M
Total Liabilities	168.7M	139.4M	145.6M	16.4M	24.7M	38.9M	51.7M	45M	39.1M	75.9M	77.2M	86.5M	138.8M	84.2M	63M	50.7M	35.3M	98.6M	84.5M	129.7M
SHAREHOLDERS' EQUITY
Preferred Stock	20.1M	49K	49K	49K	49K	49K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1K	1K	1K	1K	1K
Common Stock	89K	90K	86K	86K	85K	84K	73K	65K	62K	46K	893K	869K	787K	615K	263K	214K	101K	70K	66K	53K
Additional Paid-In Capital	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.2B	1.2B	1.2B	1.1B	1.1B	1.1B	1.1B	978M	900.8M	876.7M	802M	724M	740.1M	659.7M
Retained Earnings	-1.2B	-1.2B	-1.2B	-1.2B	-1.2B	-1.2B	-1.2B	-1.2B	-1.2B	-1.2B	-1.1B	-1.1B	-1.1B	-957.1M	-886.1M	-853.3M	-784.6M	-785.1M	-739.9M	-727.5M
Accumulated Other Comprehensive Income/Loss	53K	73K	0.0	0.0	0.0	0.0	0.0	-70K	-41K	-13.5M	-15.5M	0.0	-1K	8K	-43.5M	-38.8M	0.0	-2K	-9K	-9K
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6M	0.0	29.6M
Total Stockholders' Equity	104M	81.9M	88.7M	124M	141.9M	86.4M	44M	18.8M	5.8M	-47.2M	-2.3M	3.1M	-4M	21.5M	15M	23.6M	17.5M	-31.4M	318K	-38.2M
Total Equity	104M	81.9M	88.7M	124M	141.9M	86.4M	44M	18.8M	5.8M	-47.2M	-2.3M	3.1M	-4M	21.5M	15M	23.6M	17.5M	-31.4M	318K	-38.2M
SUMMARY
Total Liabilities & Equity	272.7M	221.3M	234.3M	140.4M	166.6M	125.3M	95.7M	63.8M	44.9M	28.7M	74.9M	89.6M	134.8M	105.7M	78M	74.3M	52.8M	67.2M	84.8M	91.5M
Total Investments	106.8M	67.9M	64.2M	64M	774K	1.7M	681K	392K	0.0	0.0	496K	0.0	20M	40M	0.0	0.0	0.0	1.3M	16.1M	18.4M
Total Debt	131.6M	119.2M	124.5M	34K	229K	21.3M	32.8M	22.5M	14.6M	43.2M	48.7M	35.5M	41M	41M	33.5M	13.7M	13.3M	63.3M	50.9M	98.2M
Net Debt	48.6M	17.5M	-28.8M	-57.8M	-93.1M	-63M	-23.8M	-23.3M	-28.9M	17.4M	-17.1M	-42.9M	-60.7M	-4.3M	-14.8M	-23.6M	-10.6M	53.8M	28.4M	70.2M
Shares Outstanding	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918	11,888,918

SEC Filings

XOMA - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 22, 2026	May 21, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 18, 2026	May 16, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 12, 2026	March 31, 2026	2026	View Filing
8-K/A 8-K/A 2026 (Amended) N/A	April 27, 2026	February 09, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 27, 2026	April 27, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 30, 2026	May 21, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 18, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 18, 2026	March 18, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 02, 2026	March 02, 2026	2026	View Filing
8-K/A 8-K/A 2025 (Amended) N/A	February 02, 2026	November 21, 2025	2025	View Filing

Showing 1 to 10 of 473 filings

Related Guides

Blog Categories

Continue your XOMA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.